Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04165317 |
|---|---|
| Brief Title: | Study of Sasanlimab (PF-06801591) in Combination With Bacillus Calmette-Guerin (BCG) in Participants With High-Risk Non-Muscle Invasive Bladder Cancer (CREST) |
| First Submitted : | November 13, 2019 |
| First Submitted that Met QC Criteria : | November 13, 2019 |
| First Posted : | November 15, 2019 |
| Last Update Submitted that Met QC Criteria : | June 29, 2021 |
| Last Update Posted : | July 1, 2021 |